Dr. William D. Buchanan

Dr. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.After receiving his medical degree from Yale University School of Medicine, Dr. Waxman completed a residency in internal medicine at Yale New Haven Hospital. He then completed two fellowships: the first at Howard Hughes Medical Institute, and the second in pulmonary and critical care at Yale New Haven Hospital. He is board certified in critical care medicine, internal medicine and pulmonary disease.Dr. Waxman’s clinical interests include pulmonary arterial hypertension (PAH), right heart failure, thromboembolic disease and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure. His research into the regulation of cell death proteins by IL-6 cytokines in mice led to the discovery of a relationship between dyspnea and mitochondrial dysfunction, and resulted in additional clinical studies examining the abnormalities of inflammatory mediators and oxygen extraction in patients with PAH. He has authored over 110 peer-reviewed publications and has received funding from the National Institutes of Health and the National Heart, Lung, and Blood Institute. Dr. Waxman is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Cor Pulmonale, Pulmonary Veno-Occlusive Disease, and Thrombectomy. Dr. Waxman is board certified in Pulmonary Disease, Internal Medicine, and Critical Care Medicine. Dr. Waxman is currently accepting new patients.

Dr. Edwin Kepner Silverman is chief of the Channing Division of Network Medicine and a physician at Brigham and Women’s Hospital (BWH). He is also a professor of medicine at Harvard Medical School.He received his medical degree from Washington University School of Medicine. He then completed a residency in internal medicine and a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary medicine.Dr. Silverman’s clinical interests include alpha 1-antitrypsin deficiency, emphysema, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). He has served as a principal investigator of multiple COPD genetics studies funded by the National Institutes of Health, including the NETT Genetics Ancillary Study, the Transcontinental COPD Genetics Study, the Alpha-1 Antitrypsin Genetic Modifiers Study and the COPDGene Study. His research uses a variety of genetic analysis approaches to investigate the genetic influences of complex lung diseases, including integrative genomics, linkage analysis, familial aggregation analysis, rare variant analysis and epigenetic studies. He has authored over 320 peer-reviewed publications and is the recipient of the BWH Kenneth L. Baughman Faculty Mentoring Award. Dr. Silverman is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Emphysema, Pulmonary Fibrosis, and Respiratory Syncytial Virus (RSV) Infection. Dr. Silverman is currently accepting new patients.

Erik Folch is an Intensive Care Medicine provider practicing medicine in Boston, Massachusetts. Dr. Folch is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Emphysema, Advanced Bronchoscopy, and Endoscopy. Dr. Folch is currently accepting new patients.

Dr. Chanu Rhee is an infectious disease and critical care physician, Medical Director of Infection Control at Brigham and Women’s Hospital, and Associate Professor of Medicine at Harvard Medical School. He graduated summa cum laude from Georgetown University School of Medicine and completed his internal medicine residency, chief residency, and critical care medicine fellowship at Stanford University Hospital followed by an infectious disease fellowship in the combined Massachusetts General Hospital / Brigham and Women’s Hospital program and an MPH degree from the Harvard T.H. Chan School of Public Health. Dr. Rhee is internationally recognized for his expertise and contributions to the epidemiology, surveillance, diagnosis, and treatment of sepsis, particularly through the innovative use of electronic health record data to generate insights that inform clinical practice, quality improvement, and public health policy. His areas of focus also include infection prevention and control, antimicrobial resistance and stewardship, infections in immunocompromised patients, and the care of critically ill patients. He has been a leader in sepsis quality improvement efforts within the Mass General Brigham healthcare system and has participated in many national committees focused on enhancing sepsis care and outcomes, including in his current role as Chair of the Infectious Diseases Society of America’s Sepsis Advisory Panel.Dr. Rhee attends clinically on the transplant / oncology infectious disease service and the Medical ICU at Brigham and Women’s Hospital. In his role as Medical Director of Infection Control, he leads institutional efforts to prevent healthcare-associated infections, investigate outbreaks, and advance patient safety. He is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a Fellow of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Critical Care Medicine. He has served as principal or lead investigator on multiple federally funded grants, has authored over 200 peer-reviewed articles, and is recognized by ScholarGPS as one of the world’s most highly cited and influential experts on sepsis. Dr. Rhee is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Sepsis, Hospital-Acquired Pneumonia, Severe Acute Respiratory Syndrome (SARS), and Pneumonia. Dr. Rhee is board certified in Infectious Disease, Internal Medicine, and Critical Care Medicine. Dr. Rhee is currently accepting new patients.

Dr. Hisashi Tsukada is a thoracic surgeon at Brigham and Women’s Hospital.  He is also an assistant professor in surgery at Harvard Medical School. He received his medical degree and a PhD in medicine from St. Marianna University School of Medicine (Kawasaki, Japan). He then completed a residency in surgery at Mitsui Memorial Hospital (Tokyo). His fellowships include thoracic surgery at St. Marianna University Hospital, thoracic surgery research at Beth Israel Deaconess Medical Center and interventional pulmonology at St. Elizabeth’s Medical Center.   Dr. Tsukada specializes in Interventional Pulmonology and his clinical interests concentrate on aligning his research investigations to disease processes he has observed in patients as a practicing thoracic surgeon for more than ten years in Japan. Dr. Tsukada started his service at Brigham and Women’s Hospital in October 2014. He has expanded the Interventional Pulmonology procedures up to 1,000 cases per year in 2023. Dr. Tsukada is research focuses on developing an artificial trachea for in vivo implantation and airway tissue regeneration. He has authored 30 peer-reviewed publications. Dr. Tsukada is fluent in Japanese. Dr. Tsukada is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lymphofollicular Hyperplasia, Mesothelioma, Advanced Bronchoscopy, and Endoscopy. Dr. Tsukada is board certified in Bronchology & Interventional Pulmonology. Dr. Tsukada is currently accepting new patients.

Samuel Ash is an Intensive Care Medicine provider practicing medicine in Boston, Massachusetts. He has been practicing medicine for over 17 years. Dr. Ash is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Emphysema and Pulmonary Fibrosis. Dr. Ash is currently accepting new patients.